Answers are grounded in this paper and cite their sources.
Sepsis is a life-threatening syndrome characterized by infection-induced organ dysfunction and dysregulated host inflammatory responses. Despite advances in supportive care, effective pharmacological therapies remain lacking. Growth arrest-specific protein 6 (Gas6), a vitamin K-dependent ligand of the TAM receptors (Tyro3, Axl, and Mer), operates at the interface of inflammation and coagulation. Here, we investigated the role of Gas6-TAM signaling in endotoxemia and infection in humans and mice. Plasma Gas6 levels increased rapidly during sepsis in patients, during experimental endotoxemia in both humans and mice, and during infection in mice, and these elevations correlated with disease severity and poor clinical outcomes. In both species, circulating Gas6 remained closely balanced with soluble Axl (sAxl), suggesting that much of plasma Gas6 is sequestered in soluble complexes, thereby limiting activation of membrane TAM receptors. In mice, deficiency of Gas6 or individual TAM receptors increased susceptibility to endotoxemia, and Gas6 deficiency additionally heightened vulnerability to bacterial infection. Gas6-deficient mice displayed reduced mean blood pressure, exaggerated cytokine release, altered early leukocyte dynamics, and enhanced macrophage activation. Mechanistically, macrophages secreted Gas6 in response to LPS, and Gas6 acted as an autocrine negative feedback signal limiting inflammatory cytokine production, at least in part through regulation of TLR signaling. Although Gas6 is strongly involved in immune regulation during sepsis, our data do not support a major direct role in coagulation activation. While circulating Gas6 and soluble Mer levels in septic patients were associated with sepsis-induced coagulopathy and impaired thrombin generation, this likely reflects disease severity rather than a causal effect on the coagulation. Consistently, in a murine endotoxemia model, Gas6 deficiency resulted in only minor changes in coagulation markers and did not lead to disseminated intravascular coagulation, suggesting that Gas6 primarily reflects systemic inflammation rather than directly driving coagulation abnormalities.
No takes yet. Share an insight, caveat, or question.
Çaku et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: